General Information of This Drug (ID: DMBX2RE)

Drug Name
MN-221   DMBX2RE
Synonyms Bedoradrine
Indication
Disease Entry ICD 11 Status REF
Aging skin EE40 Phase 2 [1]
Exacerbation of acute asthma CA23.30 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
MN-221 + MN-221 DCMQL0X MN-221 Asthma [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00683449) Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma. U.S. National Institutes of Health.